Inventor · disambiguated record
Christian Griesinger
Also filed as: GRIESINGER CHRISTIAN
10 granted patents·3 pending applications·71 citations·filing 1996–2022
85Inventor score
Files withMAX PLANCK GESELLSCHAFT3BASF AG2MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V2GIESE ARMIN1KOREA BASIC SCIENCE INST1
Top patents by PatentIndex Score
13 records- 0179US5741892APentapeptides as antitumor agentsBASF AG·Filed 1996·Granted Apr 21, 1998·50 cites·8 claims
- 0278US10071966B2Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseasesUNIV MUENCHEN LUDWIG MAXIMILIANS·Filed 2015·Granted Sep 11, 2018·5 cites·13 claims
- 0372US10308671B2Water-soluble derivatives of 3,5-diphenyl-diazole compoundsMAX PLANCK GESELLSCHAFT·Filed 2016·Granted Jun 4, 2019·1 cites·18 claims
- 0467US10435373B2Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseasesLUDWIG MAXIMILIANS UNIV MUNCHEN·Filed 2018·Granted Oct 8, 2019·2 cites·14 claims
- 0565US8809505B2Mutant alpha-synuclein, and methods using sameZWECKSTETTER MARKUS·Filed 2009·Granted Aug 19, 2014·1 cites·9 claims
- 0660US9253964B2Mutant alpha-synuclein, and methods using sameMAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V·Filed 2014·Granted Feb 9, 2016·0 cites·8 claims
- 0758US2025228242A1Protein aggregation inhibiting compounds for plant disease controlMAX PLANCK GESELLSCHAFT·Filed 2022·Application pending·0 cites
- 0855US9247721B2Transgenic non-human animal comprising a mutant alpha-synucleinMAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V·Filed 2014·Granted Feb 2, 2016·0 cites·23 claims
- 0955US2011293520A1New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseasesGIESE ARMIN·Filed 2009·Application pending·0 cites
- 1053US11744839B2Method of increasing platelet counts of a subjectKOREA BASIC SCIENCE INST·Filed 2021·Granted Sep 5, 2023·0 cites·6 claims
- 1152US5939527ATetrapeptides as antitumor agentsBASF AG·Filed 1996·Granted Aug 17, 1999·12 cites·15 claims
- 1248US2023067910A1Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synucleinMODAG GMBH·Filed 2020·Application pending·0 cites
- 1340US11180518B2Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanomaMAX PLANCK GESELLSCHAFT·Filed 2018·Granted Nov 23, 2021·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →